9p21 and the genetic revolution for coronary artery disease

Clinical Chemistry

Volumn 58, Issue 1, 2012, Pages 104-112

  Roberts, Robert ^a   Stewart, Alexandre F R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COMPLEMENTARY RNA; CYCLIN DEPENDENT KINASE INHIBITOR 2B; PROTEIN P15; PROTEIN P16; VON WILLEBRAND FACTOR;

ABDOMINAL AORTA ANEURYSM; ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL GROWTH; CELL PROLIFERATION; CHINESE; CHROMOSOME 9P; CHROMOSOME POSITIONING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA MARKER; ETHNIC GROUP; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEART INFARCTION; HUMAN; HYPERTENSION; INTRACRANIAL ANEURYSM; MELANOMA; META ANALYSIS (TOPIC); PHYLOGENY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; THROMBOSIS;

AORTIC ANEURYSM, ABDOMINAL; BIOLOGICAL MARKERS; CHROMOSOMES, HUMAN, PAIR 9; CORONARY ARTERY DISEASE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INTRACRANIAL ANEURYSM; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84856068773     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.172759     Document Type: Review

References (70)

1. Yusuf S, Hawken S, Ounpuu S, Dans T, Awezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52. (Pubitemid 39208455)
2. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-23. (Pubitemid 36776151)
3. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al., for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333:1301-8.
4. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al., for AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998;279:1615-22. (Pubitemid 28248586)
5. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al., for the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2011;361:1149-58.
6. Chan L, Boerwinkle E. Gene-environment interactions and gene therapy in atherosclerosis. Cardiol Rev 1994;2:130-7.
7. Hopkins PN, Williams RR, Kuida H, Stults BM, Hunt SC, Barlow GK, Ash KO. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol 1988;62:703-7.
8. Lloyd-Jones DM, Nam BH, D'Agostino RB, Levy D, Murabito JM, Wang TJ, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA 2004;291:2204-11. (Pubitemid 38608169)
9. Cooper JA, Miller GJ, Humphries SE. A comparison of the PROCAM and Framingham pointscoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis 2005;181:93-100. (Pubitemid 40804698)
10. World Health Organization. Facing the facts: the impact of chronic disease in Canada. http://www.who.int/chp/chronic-disease-report/media/CANADA. pdf (Accessed October 2011).
11. Sidhu J, Rajawat YS, Rami TG, Gollob MH, Wang Z, Yuan R, et al. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome. Circulation 2005;111:21-9. (Pubitemid 40070839)
12. Roberts R. A customized genetic approach to the number one killer: coronary artery disease. Curr Opin Cardiol 2008;23:629-33.
13. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet 1999;22:139-44. (Pubitemid 29264806)
14. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108. (Pubitemid 40179532)
15. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG, et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005;307:1072-9. (Pubitemid 40262106)
16. Pare G, Serre D, Brisson D, Anand S, Montpetit A, Tremblay G, et al. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet 2007;80:673-82. (Pubitemid 46564404)
17. Morgan TM, Krumholz HM, Lifton RP, Spertus JA. Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 2007;297:1551-61. (Pubitemid 46588368)
18. Petretto E, Liu ET, Aitman T. A gene harvest revealing the archeology and complexity of human disease. Nat Genet 2007;39:1299-301. (Pubitemid 350035009)
19. McPherson R, Pertsemlidis A, Kavaslar N, Stewart AFR, Roberts R, Cox DR, et al. A common allele on chromosome 9 associated with coronary heart disease. Science 2007;316:1488-91. (Pubitemid 46906617)
20. Helgadottir A, Thorleifsson G, Manolescu A, Gretarsdottir S, Blondal T, Jonasdottir A, et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 2007;316:1491-3. (Pubitemid 46906618)
21. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007;447:661-78.
22. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-6.
23. Broadbent HM, Peden JF, Lorkowski S, Goel A, Ongen H, Green F, et al. Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Hum Mol Genet 2008;17:806-14. (Pubitemid 351359697)
24. Palomaki GE, Melillo S, Bradley LA. Association between 9p21 genomic markers and heart disease: a meta-analysis. JAMA 2010;303:648-56.
25. Ding H, Xu Y, Wang X, Wang Q, Zhang L, Tu Y, et al. 9p21 is a shared susceptibility locus strongly for coronary artery disease and weakly for ischemic stroke in Chinese Han population. Circ Cardiovasc Genet 2009;2:338-46.
26. Shen GQ, Li L, Rao S, Abdullah KG, Ban JM, Lee BS, et al. Four SNPs on chromosome 9p21 in a South Korean population implicate a genetic locus that confers high cross-race risk for development of coronary artery disease. Arterioscler Thromb Vasc Biol 2008;28:360-5. (Pubitemid 351161212)
27. Shen GQ, Rao S, Martinelli N, Li L, Olivieri O, Corrocher R, et al. Association between four SNPs on chromosome 9p21 and myocardial infarction is replicated in an Italian population. J Hum Genet 2007;53:144-50.
28. Hinohara K, Nakajima T, Takahashi M, Hohda S, Sasaoka T, Nakahara K, et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations. J Hum Genet 2008;53:357-9.
29. Zhou L, Zhang X, He M, Cheng L, Chen Y, Hu FB, Wu T. Associations between single nucleotide polymorphisms on chromosome 9p21 and risk of coronary heart disease in Chinese Han population. Arterioscler Thromb Vasc Biol 2008;28:2085-9.
30. Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. Hum Mol Genet 2008;17:2320-8.
31. Coronary Artery Disease (C4D) Genetics Consortium. A genome-wide association study in Europeans and South Asians identifies five new loci for coronary artery disease. Nat Genet 2001;43:339-44.
32. U.S. Department of Health & Human Services. Office of the Surgeon General. The health consequences of smoking: a report of the Surgeon General. May 27, 2004. http://www.surgeongeneral.gov/library/smokingconsequences/ (Accessed October 2011).
33. McPherson R. Chromosome 9p21 and coronary artery disease. N Engl J Med 2010;362:1736-7.
34. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindroff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-53.
35. Brown MS, Goldstein JL. Familial hypercholesterolemia: a genetic defect in the low density lipoprotein receptor. N Engl J Med 1976;294:1386-90.
36. Helgadottir A, Thorleifsson G, Magnusson KP, Grétarsdottir S, Steinthorsdottir V, Manolescu A, et al. The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nat Genet 2008;40:217-24. (Pubitemid 351171400)
37. Bilguvar K, Yasuno K, Niemelä M, Ruigrok YM, von und zu Fraunberg M, van Duijn CM, et al. Susceptibility loci for intracranial aneurysm in European and Japanese populations. Nat Genet 2008;40:1472-7.
38. Wahlstrand B, Orho-Melander M, Delling L, Kjeldsen S, Narkiewicz K, Almgren P, et al. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension. J Hypertens 2009;27:769-73.
39. Yasuno K, Bilguvar K, Bijlenga P, Low SK, Krischek B, Auburger G, et al. Genome-wide association study of intracranial aneurysm identifies three new risk loci. Nat Genet 2010;42:420-5.
40. Matarin M, Brown MH, Singleton A, Hardy JA, Meschia JF. Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke 2008;39:1586-9.
41. Pasmant E, Laurendeau I, Héron D, Vidaud M, Vidaud D, Bieche I. Characterization of a germline deletion, including the entire INK4/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF. Cancer Res 2007;67:3963-9. (Pubitemid 46762186)
42. Ivanchuk SM, Mondal S, Dirks PB, Rutka JT. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth. J Neurooncol 2001;51:219-29. (Pubitemid 32479296)
43. Ink4a. Nature 2007;448:943-6.
44. Jarinova O, Stewart AFR, Roberts R, Wells G, Lau P, Naing T, et al. Functional analysis of the chromosome 9p21.3 coronary artery disease risk locus. Arterioscler Thromb Vasc Biol 2009;29:1671-7.
45. Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, et al. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature 2011;470:264-8.
46. Dandona S, Stewart AFR, Chen L, Williams K, So D, O'Brien E, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disease. J Am Coll Cardiol 2009;56:479-86.
47. Chen Z, Qian Q, Ma G, Wang J, Zhang X, Feng Y, et al. A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease. Mol Biol Rep 2009;36:889-93.
48. Patel RS, Su S, Neeland IJ, Ahuja A, Veledar E, Zhao J, et al. The chromosome 9p21 risk locus is associated with angiographic severity and progression of coronary artery disease. Eur Heart J 2010;31:3017-23.
49. Ardissino D, Berzuini C, Merlini PA, Mannucci MP, Surti A, Burtt N, et al. Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction. J Am Coll Cardiol 2011;58:426 -34.
50. Anderson JL, Horne BD, Kolek MJ, Muhlestein JB, Mower CP, Park JJ, et al. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J 2008;156:1155-62.
51. Anderson JL, Horne BD. The 9p21 locus and coronary heart disease: initiator, promoter, or precipitator? J Am Coll Cardiol 2010;56:487-9.
52. Yap KL, Li S, Muñoz-Cabello AM, Raquz S, Zeng L, Mujitaba S, et al. Molecular interplay of the non-coding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 2010;38:662-74.
53. Visel A, Zhu Y, May D, Afzal V, Gong E, Attanasio C, et al. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice. Nature 2010;464:409-12.
54. Dandona S, Stewart AFR, Roberts R. Genomics in coronary artery disease: past, present and future. Can J Cardiol 2010;26(Suppl A):56A-9A.
55. Preuss M, König IR, Thompson JR, Erdmann J, Absher D, Assimes TL, et al., and on behalf of the CARDIoGRAM Consortium. Design of the Coronary ARtery Disease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Study: a genome-wide association meta-analysis involving more than 22 000 cases and 60 000 controls. Circ Cardiovasc Genet 2010;3:475-83.
56. Schunkert H, König IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011;43:333-8.
57. Reilly MP, Li M, He J, Ferguson JF, Stylianou IM, Mehta NN, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011;377:383-92.
58. Wang F, Xu CQ, He Q, Cai JP, Li XC, Wang D, et al. Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet 2011;43:345-9.
59. Schaefer EJ, Lamon-Fava S, Jenner JL, McNamara JR, Ordovas JM, Davis CE, et al. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA 271:999-1003.
60. Sesso HD, Stampfer MJ, Rosner B, Hennekens CH, Gaziano JM, Manson JE, Glynn RJ. Systolic and diastolic blood pressure, pulse pressure, and mean arterial pressure as predictors of cardiovascular disease risk in men. Hypertension 2000;36:801-7.
61. Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 302:1993-2000.
62. Paynter NP, Chasman DI, Paré G, Buring J, Cook NR, Miletich JP, Ridker PM. Association between a literature-based genetic risk score and cardiovascular events in women. JAMA 2010;303:631-7.
63. Davies RW, Dandona S, Stewart AFR, Chen L, Ellis S, Tang WH, et al. Improved prediction of cardiovascular disease based on a panel of single nucleotide polymorphisms identified through genome-wide association studies. Circ Cardiovasc Genet 2010;3:468-74.
64. Talmud PJ, Cooper JA, Palmen J, Lovering R, Drenos F, Hingorani AD, Humphries SE. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem 2008;54:467-74. (Pubitemid 351348157)
65. Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009;41:334-41.
66. Samani NJ, Erdmann J, Hall AS, Hengstenberg C, Mangino M, Mayer B, et al., for the WTCCC and the Cardiogenics Consortium. Genome-wide association analysis of coronary artery disease. N Engl J Med 2007;357:443-53. (Pubitemid 47204873)
67. Erdmann J, Groszhennig A, Braund PS, König IR, Hengstenberg C, Hall AS, et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 2009;41:280-2.
68. Trégouët DA, König IR, Erdmann J, Munteanu A, Braund PS, Hall AS, et al. Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 2009;41:283-5.
69. Gudbjartsson D, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009;41:342-7.
70. Soranzo N, Spector TD, Mangino M, Kuhnel B, Rendon A, Teumer A, et al. A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 2009;41:1182-90.